MUMBAI, India, June 20 -- Intellectual Property India has published a patent application (202321086787 A) filed by Intas Pharmaceuticals Ltd., Ahmedabad, Gujarat, on Dec. 19, 2023, for 'method for reducing oxidation levels in vedolizumab during cell culture process.'
Inventor(s) include Dr. Velu Mahalingam; Kinchit Shah; Hiral S. Patel; Panchaxari Chitti; and Dr. Laxmi Adhikary.
The application for the patent was published on June 20, under issue no. 25/2025.
According to the abstract released by the Intellectual Property India: "The present invention provides a method of producing Vedolizumab, comprising supplementing cell culture with Methionine and thereby reducing the oxidation of cell culture."
Disclaimer: Curated by HT Syndication...